In the rapidly advancing field of CRISPR-based therapeutic development, the transition from Research-Use Only (RUO) to Good Manufacturing Practice (GMP) compliance presents significant challenges. Synthego’s innovative solutions are engineered specifically to address these challenges within the CRISPR RUO-to-GMP continuum. Our continuum offers unparalleled scalability, enabling researchers and developers to increase production without compromising quality. By leveraging our extensive technical and regulatory expertise, we help you mitigate the risks of delays that can hinder project timelines. Moreover, we facilitate informed decision-making by offering simplified licensing structures for CRISPR systems, crucial for successful downstream commercialization and clinical trials. With Synthego, you gain a trusted partner poised to elevate your therapeutic development aspirations.
Our commitments are simple:
Contract Manufacturing
Our company has developed a range of services intended to accelerate our customers' discovery processes.
Antibody Development
Our company has developed a range of services intended to accelerate our customers' discovery processes.
Additional Information
Below is a selection of downloads which contain more information on the suppliers technology.
Contacts
Contact Labospace
Are you interested in our microbiome service?
We’re here to help with your project. Just complete the form when you're ready to get started.